Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $166.50 | 3 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $124.98 | 1 | $0 (2022) |
| Gilead Sciences, Inc. | $21.82 | 1 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $19.70 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $124.98 | 1 | AstraZeneca Pharmaceuticals LP ($124.98) |
| 2021 | $21.82 | 1 | Gilead Sciences, Inc. ($21.82) |
| 2019 | $19.70 | 1 | Merck Sharp & Dohme Corporation ($19.70) |
All Payment Transactions
3 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/30/2022 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $124.98 | General |
| Category: Rare Disease | ||||||
| 11/04/2021 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $21.82 | General |
| 06/13/2019 | Merck Sharp & Dohme Corporation | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $19.70 | General |
| Category: WOMENS HEALTH | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 382 | 402 | $324,798 | $36,316 |
| 2022 | 14 | 1,316 | 1,379 | $766,128 | $91,289 |
| 2021 | 13 | 1,416 | 1,542 | $933,718 | $116,234 |
| 2020 | 14 | 662 | 674 | $296,168 | $40,144 |
All Medicare Procedures & Services
45 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 78815 | Nuclear medicine study from skull base to mid-thigh with ct scan | Facility | 2023 | 364 | 384 | $315,888 | $35,316 | 11.2% |
| 78608 | Nuclear medicine study of brain with metabolic evaluation | Facility | 2023 | 18 | 18 | $8,910 | $1,000 | 11.2% |
| 78815 | Nuclear medicine study from skull base to mid-thigh with ct scan | Facility | 2022 | 512 | 564 | $450,626 | $52,870 | 11.7% |
| 78815 | Nuclear medicine study from skull base to mid-thigh with ct scan | Office | 2022 | 157 | 165 | $131,525 | $15,408 | 11.7% |
| 78580 | Nuclear medicine study of lung circulation | Facility | 2022 | 168 | 168 | $40,138 | $4,870 | 12.1% |
| 78608 | Nuclear medicine study of brain with metabolic evaluation | Facility | 2022 | 70 | 70 | $33,096 | $3,916 | 11.8% |
| 78306 | Nuclear medicine study of bone and/or joint whole body | Facility | 2022 | 93 | 94 | $26,168 | $3,111 | 11.9% |
| 78264 | Nuclear medicine study of stomach to assess emptying | Facility | 2022 | 79 | 79 | $19,629 | $2,452 | 12.5% |
| 78227 | Nuclear medicine study of liver and bile duct system with use of drugs | Facility | 2022 | 44 | 44 | $11,512 | $1,565 | 13.6% |
| 78226 | Nuclear medicine study of liver and bile duct system | Facility | 2022 | 46 | 46 | $8,986 | $1,335 | 14.9% |
| 78072 | Nuclear medicine study of parathyroid with spect and ct scan | Facility | 2022 | 18 | 18 | $7,554 | $1,112 | 14.7% |
| 38792 | Injection of radioactive material for x-ray identification of lymph node | Facility | 2022 | 37 | 37 | $6,663 | $1,002 | 15.0% |
| 78315 | Nuclear medicine study of bone taken at different times | Facility | 2022 | 22 | 22 | $7,272 | $867.89 | 11.9% |
| 78278 | Nuclear medicine study to assess blood loss | Facility | 2022 | 21 | 22 | $6,978 | $851.47 | 12.2% |
| 78708 | Nuclear medicine study of kidney, blood, flow, and function with drug administration | Facility | 2022 | 15 | 16 | $4,999 | $753.12 | 15.1% |
| 78597 | Nuclear medicine study of lung ventilation and blood flow to lung | Facility | 2022 | 22 | 22 | $4,200 | $620.40 | 14.8% |
| 78071 | Nuclear medicine study of parathyroid with spect | Facility | 2022 | 12 | 12 | $6,782 | $556.62 | 8.2% |
| 78815 | Nuclear medicine study with ct imaging skull base to mid-thigh | Facility | 2021 | 548 | 613 | $476,078 | $58,693 | 12.3% |
| 78815 | Nuclear medicine study with ct imaging skull base to mid-thigh | Office | 2021 | 335 | 390 | $302,660 | $37,189 | 12.3% |
| 78608 | Nuclear medicine study brain with metabolic evaluation | Facility | 2021 | 99 | 99 | $45,522 | $5,715 | 12.6% |
| 78580 | Nuclear medicine study of blood circulation in the lungs | Facility | 2021 | 147 | 149 | $34,675 | $4,425 | 12.8% |
| 78306 | Bone and/or joint imaging, whole body | Facility | 2021 | 88 | 92 | $25,024 | $3,160 | 12.6% |
| 78226 | Imaging of liver and bile duct system | Facility | 2021 | 43 | 43 | $8,164 | $1,281 | 15.7% |
| 78264 | Stomach emptying study | Facility | 2021 | 31 | 31 | $7,502 | $986.37 | 13.1% |
| 78278 | Acute digestive tract blood loss imaging | Facility | 2021 | 20 | 20 | $6,171 | $792.69 | 12.8% |
About Dr. Daniel Lee, M.D
Dr. Daniel Lee, M.D is a Nuclear Medicine healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/26/2008. The National Provider Identifier (NPI) number assigned to this provider is 1780839183.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Lee, M.D has received a total of $166.50 in payments from pharmaceutical and medical device companies, with $124.98 received in 2022. These payments were reported across 3 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($166.50).
As a Medicare-enrolled provider, Lee has provided services to 3,776 Medicare beneficiaries, totaling 3,997 services with total Medicare billing of $283,982. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.
Practice Information
- Specialty Nuclear Medicine
- Other Specialties Nuclear Medicine
- Location Houston, TX
- Active Since 11/26/2008
- Last Updated 11/26/2008
- Taxonomy Code 207U00000X
- Entity Type Individual
- NPI Number 1780839183
Products in Payments
- ANDEXXA (Biological) $124.98
- NEXPLANON (Drug) $19.70
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nuclear Medicine Doctors in Houston
Arash Kardan, Md, MD
Nuclear Medicine — Payments: $24,953
Dr. Beth Chasen, M.d, M.D
Nuclear Medicine — Payments: $11,846
Lesley Flynt, Md, MD
Nuclear Medicine — Payments: $8,005
Dr. Yang Lu, M.d., Ph.d, M.D., PH.D
Nuclear Medicine — Payments: $3,483
Simone Krebs, M.d, M.D
Nuclear Medicine — Payments: $2,893
Varaha Tammisetti, Md, MD
Nuclear Medicine — Payments: $782.39